article thumbnail

A gene test could guide decisions around chemotherapy for bowel cancer

Pharmafile

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene test which can select which advanced bowel cancer patients will respond the best to chemotherapy. read more

article thumbnail

EMA validates marketing authorisation application for Jemperli with chemotherapy

Pharmafile

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab) alongside chemotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roche extends Kaiku digital monitoring partnership again

pharmaphorum

Results of the pilot in 45 patients with non-small cell lung cancer (NSCLC) treated with Tecentriq with and without chemotherapy were published in 2020. The data showed that patients as well as physicians and nursing staff found the digital tool allowed “more efficient and focused communication” as well as time savings.

article thumbnail

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

Pharmafile

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of Lynparza (olaparib) and Imfinzi (durvalumab) alongside chemotherapy and bevacizumab. read more

article thumbnail

Hospital Universitario and Josep Carreras develop cell therapy for leukaemia

Pharmaceutical Technology

It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development.

Hospitals 110
article thumbnail

How pharmacists can counsel patients on a bad reaction to a new medication

The Checkup by Singlecare

Due to a lack of recognition and a paucity of communication between patients and healthcare providers, millions of reactions may go unreported every year. Chemotherapy . Chemotherapy drugs , such as paclitaxel, docetaxel, and procarbazine, can also cause allergic reactions, including anaphylaxis.

article thumbnail

NICE recommends new life-extending treatment for rare form of gastroesophageal cancer

Pharmafile

Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced or metastatic gastric, gastroesophageal junction, or oesophageal adenocarcinoma, if the tumours express PD-L1. read more.